| RS2065342420 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065342571 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065345592 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065346374 |
COX5A
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 20 |
| RS2065346614 |
ADA
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065348171 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065361594 |
KCNMA1
|
Health Risk |
Pathogenic |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS2065361731 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065362194 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2065374158 |
RORA
|
Health Risk |
Likely pathogenic |
— |
| RS2065377688 |
CASK
|
Health Risk |
Pathogenic |
CASK-related intellectual disability and microcephaly with pontine and cerebellar hypoplasia, CASK-related intellectual disability and microcephaly with pontine and cerebellar hypoplasia |
| RS2065377881 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS2065379291 |
CASK
|
Health Risk |
Pathogenic |
— |
| RS2065388358 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome 4 |
| RS2065449114 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome |
| RS2065449579 |
BBS4
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 4, Bardet-Biedl syndrome 4 |
| RS2065470015 |
PRICKLE3
|
Health Risk |
risk factor |
Leber optic atrophy, Leber optic atrophy |
| RS2065471243 |
RORA;RORA-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS2065474809 |
BBS4
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2065508523 |
DAGLA
|
Health Risk |
Likely pathogenic |
— |
| RS2065508863 |
SYP
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 96 |
| RS2065509989 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2065521315 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS2065521862 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS2065589645 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2065590491 |
PHF8
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Siderius type, Syndromic X-linked intellectual disability Siderius type |
| RS2065635815 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS2065638761 |
TRAPPC9
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS2065644808 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065653850 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065655753 |
CACNA1F
|
Health Risk |
Pathogenic |
Aland island eye disease, Aland island eye disease |
| RS2065655815 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2065656979 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065657421 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2065657742 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065657938 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS2065661430 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS2065661533 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065662435 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS2065663700 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2065670611 |
CACNA1F
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065688398 |
CNNM2
|
Health Risk |
Likely pathogenic |
Hypomagnesemia, seizures |
| RS2065701414 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065717075 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2065717116 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2065717735 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Retinal dystrophy |
| RS2065717955 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2065717991 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2065718031 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2065728187 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065731800 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065731921 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065735740 |
BBS4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065740868 |
CACNA1F
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065741660 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS2065742650 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2065753439 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065755060 |
ACOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2065755770 |
TBC1D24
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2065757552 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2065761154 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2065771024 |
TBC1D24
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Autosomal dominant nonsyndromic hearing loss 65 |
| RS2065771781 |
TBC1D24
|
Health Risk |
Pathogenic |
— |
| RS2065783220 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS2065786997 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant nonsyndromic hearing loss 65 |
| RS2065788445 |
TBC1D24
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 16 |
| RS2065788651 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2065791450 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2065791967 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065792758 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065792798 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065792921 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065794400 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065795260 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065795669 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2065795756 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2065808409 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2065808928 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2065825161 |
ANK2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2065829595 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS2065831369 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065831600 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065832124 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2065832850 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2065833366 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065833777 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065841382 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS2065843670 |
CACNA1F
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2065845144 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2065847886 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2065854138 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2065868148 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2065872186 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2065875711 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2065876254 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2065876304 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2065878986 |
MITF
|
Health Risk |
Pathogenic |
— |
| RS2065880189 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 2A, Aland island eye disease |
| RS2065896039 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Bardet-Biedl syndrome 4 |
| RS2065899210 |
ATP6V0C
|
Health Risk |
Pathogenic |
Seizure, EPILEPSY |